Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-GEMD in Untreated Early Non-upper Respiratory or Advanced NK/T-cell Lymphoma
NCT05774028Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Apr 2023
- Primary completion
- Apr 2024
- Modality
- DNA Intercalators/Alkylators
01
Overview
A Phase 2 trial of mitoxantrone in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
mitoxantrone
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT05774028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05774028.